Concepts (124)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Surgical Wound Infection | 4 | 2023 | 224 | 1.600 |
Why?
|
| Gastrointestinal Microbiome | 8 | 2025 | 556 | 1.070 |
Why?
|
| Diet, Western | 4 | 2020 | 42 | 0.990 |
Why?
|
| Sepsis | 4 | 2025 | 351 | 0.860 |
Why?
|
| Anastomotic Leak | 3 | 2021 | 108 | 0.840 |
Why?
|
| Drinking Water | 1 | 2022 | 68 | 0.740 |
Why?
|
| Clonidine | 1 | 2020 | 34 | 0.670 |
Why?
|
| Propranolol | 1 | 2020 | 44 | 0.670 |
Why?
|
| Anti-Bacterial Agents | 6 | 2022 | 808 | 0.660 |
Why?
|
| Serratia marcescens | 2 | 2025 | 12 | 0.650 |
Why?
|
| Alkaline Phosphatase | 2 | 2016 | 136 | 0.640 |
Why?
|
| Immune System | 1 | 2020 | 102 | 0.620 |
Why?
|
| Virulence | 3 | 2019 | 277 | 0.620 |
Why?
|
| Polyphosphates | 1 | 2018 | 8 | 0.590 |
Why?
|
| Collagenases | 1 | 2018 | 42 | 0.580 |
Why?
|
| Antihypertensive Agents | 1 | 2020 | 260 | 0.570 |
Why?
|
| Pseudomonas aeruginosa | 2 | 2021 | 207 | 0.560 |
Why?
|
| Tissue Adhesions | 1 | 2016 | 52 | 0.510 |
Why?
|
| Mice, Inbred C57BL | 12 | 2025 | 3375 | 0.480 |
Why?
|
| Inflammation | 1 | 2020 | 1024 | 0.440 |
Why?
|
| Plasminogen | 2 | 2021 | 47 | 0.340 |
Why?
|
| Colon | 3 | 2021 | 527 | 0.300 |
Why?
|
| Mice | 10 | 2025 | 12136 | 0.300 |
Why?
|
| Interleukin-6 | 2 | 2020 | 273 | 0.290 |
Why?
|
| Animals | 16 | 2025 | 28053 | 0.280 |
Why?
|
| Intestines | 3 | 2019 | 426 | 0.260 |
Why?
|
| Fecal Microbiota Transplantation | 3 | 2025 | 72 | 0.260 |
Why?
|
| Digestive System Surgical Procedures | 2 | 2018 | 134 | 0.250 |
Why?
|
| Enterococcus faecalis | 3 | 2021 | 57 | 0.240 |
Why?
|
| Serratia Infections | 1 | 2025 | 6 | 0.230 |
Why?
|
| Enterobactin | 1 | 2025 | 7 | 0.230 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2025 | 24 | 0.230 |
Why?
|
| RNA, Ribosomal, 16S | 3 | 2020 | 259 | 0.220 |
Why?
|
| Tranexamic Acid | 2 | 2021 | 40 | 0.220 |
Why?
|
| Butyrates | 2 | 2020 | 53 | 0.210 |
Why?
|
| Cecum | 2 | 2025 | 76 | 0.190 |
Why?
|
| Intestinal Mucosa | 2 | 2016 | 815 | 0.190 |
Why?
|
| Phosphates | 1 | 2022 | 163 | 0.180 |
Why?
|
| Colorectal Neoplasms | 2 | 2020 | 1041 | 0.180 |
Why?
|
| Polymers | 1 | 2022 | 201 | 0.180 |
Why?
|
| Pancreatitis, Acute Necrotizing | 1 | 2020 | 19 | 0.170 |
Why?
|
| Collagen Type IV | 1 | 2019 | 27 | 0.160 |
Why?
|
| Fibrinolysis | 1 | 2019 | 37 | 0.160 |
Why?
|
| Collagen Type I | 1 | 2019 | 74 | 0.160 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2019 | 123 | 0.160 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2019 | 51 | 0.160 |
Why?
|
| Disease Progression | 2 | 2020 | 1505 | 0.150 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2019 | 77 | 0.150 |
Why?
|
| Immunity | 1 | 2020 | 149 | 0.150 |
Why?
|
| Virus Replication | 1 | 2020 | 323 | 0.150 |
Why?
|
| C-Reactive Protein | 1 | 2019 | 205 | 0.150 |
Why?
|
| Colectomy | 1 | 2019 | 179 | 0.150 |
Why?
|
| Biofilms | 1 | 2018 | 48 | 0.140 |
Why?
|
| Models, Theoretical | 1 | 2020 | 497 | 0.140 |
Why?
|
| Wound Healing | 1 | 2019 | 371 | 0.140 |
Why?
|
| Myocardium | 1 | 2020 | 586 | 0.130 |
Why?
|
| Disease Models, Animal | 5 | 2025 | 2449 | 0.130 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2018 | 80 | 0.130 |
Why?
|
| Models, Animal | 1 | 2018 | 281 | 0.130 |
Why?
|
| Non-Nutritive Sweeteners | 1 | 2016 | 1 | 0.130 |
Why?
|
| Aspartame | 1 | 2016 | 6 | 0.130 |
Why?
|
| Ascitic Fluid | 1 | 2016 | 38 | 0.130 |
Why?
|
| Administration, Oral | 1 | 2018 | 672 | 0.130 |
Why?
|
| Antiviral Agents | 1 | 2020 | 498 | 0.130 |
Why?
|
| Comorbidity | 1 | 2020 | 986 | 0.130 |
Why?
|
| Interleukin-1beta | 1 | 2016 | 85 | 0.130 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2016 | 707 | 0.130 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 886 | 0.130 |
Why?
|
| Male | 8 | 2020 | 43927 | 0.120 |
Why?
|
| Glucose Intolerance | 1 | 2016 | 99 | 0.120 |
Why?
|
| Staphylococcal Infections | 1 | 2018 | 280 | 0.120 |
Why?
|
| Weight Loss | 1 | 2016 | 239 | 0.110 |
Why?
|
| Insulin Resistance | 1 | 2016 | 375 | 0.110 |
Why?
|
| Health Status | 1 | 2016 | 375 | 0.110 |
Why?
|
| Microbiota | 1 | 2016 | 412 | 0.090 |
Why?
|
| Postoperative Complications | 2 | 2019 | 2453 | 0.090 |
Why?
|
| Humans | 8 | 2023 | 92339 | 0.080 |
Why?
|
| Obesity | 1 | 2016 | 1014 | 0.080 |
Why?
|
| Collagen | 2 | 2021 | 303 | 0.080 |
Why?
|
| Anastomosis, Surgical | 2 | 2020 | 280 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 2 | 2020 | 1108 | 0.070 |
Why?
|
| Tryptophan | 1 | 2025 | 103 | 0.060 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2025 | 189 | 0.050 |
Why?
|
| Biomarkers | 2 | 2020 | 1847 | 0.050 |
Why?
|
| Enema | 1 | 2021 | 39 | 0.050 |
Why?
|
| Macrophages | 1 | 2025 | 601 | 0.050 |
Why?
|
| Microscopy, Confocal | 1 | 2021 | 283 | 0.040 |
Why?
|
| Fatty Acids, Volatile | 1 | 2020 | 36 | 0.040 |
Why?
|
| Butyric Acid | 1 | 2020 | 12 | 0.040 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2020 | 17 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2025 | 2097 | 0.040 |
Why?
|
| Organic Chemicals | 1 | 2019 | 36 | 0.040 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2019 | 52 | 0.040 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2020 | 106 | 0.040 |
Why?
|
| Infliximab | 1 | 2020 | 161 | 0.040 |
Why?
|
| Antifibrinolytic Agents | 1 | 2019 | 41 | 0.040 |
Why?
|
| Pseudomonas Infections | 1 | 2019 | 101 | 0.040 |
Why?
|
| Proteolysis | 1 | 2019 | 122 | 0.040 |
Why?
|
| Gastrointestinal Tract | 1 | 2020 | 192 | 0.040 |
Why?
|
| Feces | 1 | 2020 | 349 | 0.040 |
Why?
|
| Rectus Abdominis | 1 | 2018 | 41 | 0.040 |
Why?
|
| Abscess | 1 | 2018 | 95 | 0.040 |
Why?
|
| Carcinogenesis | 1 | 2019 | 223 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 1 | 2019 | 239 | 0.030 |
Why?
|
| Biotransformation | 1 | 2016 | 49 | 0.030 |
Why?
|
| Hepatectomy | 1 | 2018 | 174 | 0.030 |
Why?
|
| Phenylalanine | 1 | 2016 | 36 | 0.030 |
Why?
|
| Neutrophils | 1 | 2018 | 323 | 0.030 |
Why?
|
| Ischemia | 1 | 2018 | 254 | 0.030 |
Why?
|
| Weight Gain | 1 | 2016 | 124 | 0.030 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2016 | 137 | 0.030 |
Why?
|
| Diet, High-Fat | 1 | 2016 | 128 | 0.030 |
Why?
|
| Bacteria | 1 | 2020 | 501 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2020 | 1164 | 0.030 |
Why?
|
| Metabolic Syndrome | 1 | 2016 | 127 | 0.030 |
Why?
|
| Intestine, Small | 1 | 2016 | 301 | 0.030 |
Why?
|
| Homeostasis | 1 | 2016 | 452 | 0.030 |
Why?
|
| Phenotype | 1 | 2020 | 2502 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2016 | 651 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2016 | 855 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2020 | 3509 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2016 | 2368 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 2007 | 0.020 |
Why?
|
| Risk Factors | 1 | 2018 | 5706 | 0.020 |
Why?
|